Pharmacokinetics and safety of oral eletriptan during different phases of the menstrual cycle in healthy volunteers

Journal of Clinical Pharmacology

Volumn 41, Issue 12, 2001, Pages 1339-1344

  Shah, Ajit K ^a,d   LaBoy Goral, Lucia ^a   Scott, Nicholas ^b   Morse, Theresa ^a   Apseloff, Glen ^c  

^a PFIZER INC   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^c OHIO STATE UNIVERSITY   (United States)

^d Pizer Global Research and Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELETRIPTAN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG INDUCED DISEASE; DRUG SAFETY; ELECTROCARDIOGRAM; FEMALE; HUMAN; HUMAN EXPERIMENT; MENSTRUAL CYCLE; NORMAL HUMAN; PULSE RATE;

ADOLESCENT; ADULT; ANTIEMETICS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLICLE STIMULATING HORMONE; HALF-LIFE; HEMODYNAMIC PROCESSES; HUMANS; INDOLES; LUTEINIZING HORMONE; MENSTRUAL CYCLE; PYRROLIDINES; SPECTROPHOTOMETRY, ULTRAVIOLET; TRYPTAMINES;

EID: 0035201360     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00912700122012922     Document Type: Article

References (19)

1. Epidemiology of migraine and tension-type headache
2. The epidemiology of headache and migraine, and its meaning for neurological services
3. Prevalence of migraine headache in the United States
4. Menstruation, sex hormones, and migraine
5. Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs
6. The clinical value of eletriptan to the migraine population
7. The efficacy, safety and tolerability of oral eletriptan (40 mg and 80 mg) for the acute treatment of migraine
8. 1 receptors in migraine pathophysiology and treatment
9. 1D-like" receptor partial agonist
10. The safety, tolerability, pharmacokinetics, and pharmacodynamics of oral eletriptan in young and elderly, male and female subjects
11. Migraine with and without aura are distinct clinical entities: A study of four hundred and eighty-four male and female migraineurs from the general population
12. Determination of eletriptan in plasma and saliva using automated sequential trace enrichment of dialysate and high-performance liquid chromatography
13. The pharmacokinetics of oral eletriptan, and its excretion into breast milk in normal, healthy, nursing women
14. Menstrual migraines: Etiology, treatment and relationship to premenstrual syndrome
15. Influence of menstrual cycle and gender on alprazolam pharmacokinetics
16. Salivary paracetamol elimination kinetics during the menstrual cycle
17. Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics